Schott delivers glass vials for Covid-19 vaccine doses

Indian JV Schott Kaisha leads the supply of vials from India

277
Schott delivers pharma vials to package 2 billion doses of Covid-19 vaccines
Glass vials as packaging for a potential Covid-19 vaccine. Photo - Getty Images (Schott via internet)

German glass manufacturing giant Schott is supporting the world’s fight against Covid-19 with vials capable of holding up to 2 billion vaccination doses. The pharma glass and packaging specialist has reached agreements with leading pharmaceutical companies, including key players in India. The global agreements became effective last month, and first vials are already being delivered to companies in Asia, North America, and Europe. In India, Schott’s 50-50 joint venture, Schott Kaisha, supplies vials for Covid-19 vaccines to Serum Institute India and several other players. The joint venture operates four manufacturing facilities in the country in Jambusar and Umarsadi in Gujarat, Daman, and Baddi in Himachal Pradesh. The company also produces the pharmaceutical glass tubing for the packaging itself at its global sites, including one in Jambusar in Gujarat. The specialty glass pioneer is ideally positioned to meet the challenging demand situation since it had started an investment program into its pharma business of US $ 1 billion in 2019 already. In India, this includes a three-digit million-euro number for new Borosilicate glass melting tanks, and…

Choose your subscription to read more

Trial

0 /mo
Not sure which package to choose? Try full access
  • ₹ 0 for 4 weeks*

PSA Plan 1

1500 /year
Access to the website, weekly eMail newsletter and monthly eMag
  • ₹1,500.00 for 1 year*

PSA Plan 2

2000 /Year
Print Copy, access to the website, weekly eMail newsletter and monthly eMag
  • ₹2000 for Year*

PSA Plan 3

3600 /2Year
Print Copy, access to the website, weekly eMail newsletter and monthly eMag
  • ₹3,600.00 for 2 year*